Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Cetaphil amplia a linha Pro AD Restoraderm com foco em peles sensíveis com tendência atópica


News provided by

Galderma

Sep 05, 2023, 15:12 ET

Share this article

Share toX

Share this article

Share toX

Além do lançamento do Creme Hidratante Cetaphil Pro AD Restoraderm, a fórmula da Loção Hidratante Cetaphil Pro AD Restoraderm teve sua fórmula aprimorada e ganhou nova versão em 145mL

SÃO PAULO, 5 de setembro de 2023 /PRNewswire/ -- Comprometida em desenvolver dermocosméticos para o cuidado de todos os tipos de pele, inclusive as mais sensíveis, Cetaphil acaba de ampliar sua linha Pro AD Restoraderm, indicada para peles com tendência atópica. Além do lançamento do Creme Hidratante Pro AD Restoraderm, a Loção Hidratante Pro AD Restoraderm teve a sua fórmula aprimorada com a tecnologia AD-Resyl, que reestabelece o equilíbrio do microbioma cutâneo1. Essa mesma loção também ganhou um novo tamanho, na embalagem de 145mL.

Continue Reading

Ao todo, são 5 produtos da marca mais recomendada pelos dermatologistas2 voltados para cuidados corporais e faciais, da limpeza à hidratação, que apresentam em sua composição ingredientes que hidratam, acalmam e aliviam o prurido (que causa a sensação de coceira) da pele muito seca e irritada3. A filagrina e as ceramidas presentes nos produtos ajudam a melhorar a hidratação e a recuperar a barreira cutânea4. Já a tecnologia AD-Resyl, presente nas loções da linha, realiza a manutenção do microbioma da pele5, uma barreira protetora composta por microrganismos.

A dermatologista Daniela Pimentel (CRM SP0112165) explica que "o ressecamento é o principal responsável por sintomas como coceira e a descamação. Por isso, para conseguir prolongar o tempo entre as crises alérgicas, além de identificar quais são os gatilhos que desencadeiam reações na pele, é sempre recomendado o uso de hidratantes potentes, mas que tenham ingredientes calmantes para conter a irritação. Filagrina e ceramidas são excelentes aliados, por também atuarem na recuperação e no fortalecimento da barreira cutânea".

Os produtos de Cetaphil Pro AD Restoraderm também podem ser utilizados em pacientes pediátricos. A linha conta com: o Creme Hidratante Pro AD Restoraderm, a Loção Hidratante Pro AD Restoraderm (295mL e 145mL) e o Sabonete Líquido Pro AD Restoraderm, liberados para uso a partir dos 3 meses de idade6-7-8, e a Espuma Hidratante Pro AD Fast Control, a partir dos 7 meses9. "Quem tem a pele com tendência atópica normalmente manifesta sinais nos primeiros meses ou anos de vida. Nesses casos, produtos de aplicação tópica são muito bem-vindos já que a higienização com produtos adequados e a hidratação específica são pilares fundamentais nos cuidados diários desses pacientes", pontua a especialista.

"Os nossos produtos são pensados para atender todos os tipos de pele, inclusive as mais sensíveis, como as peles atópicas. A ampliação da linha e o aprimoramento da fórmula da loção hidratante reforçam o nosso compromisso com essa jornada, pautado pelo avanço da ciência, tecnologia e inovação. Além de oferecer um cuidado ainda mais completo para quem sofre com o ressecamento e a irritação, vamos continuar fazendo parte da rotina de médicos e pacientes que confiam na eficácia das nossas fórmulas", comenta Claudia Paz, gerente de Estratégia Digital & DTC da franquia de Skincare Dermatológico da Galderma.

Conheça todos os detalhes dos produtos:

O mais novo integrante da linha, o Creme Hidratante Cetaphil Pro AD Restoraderm mantém a pele hidratada por 48 horas após 1 aplicação10, o que ajuda aliviar o ressecamento e o prurido da pele sensível11-12. Também age na recuperação significativa da barreira cutânea em 24 horas13.

 A Loção Hidratante Cetaphil Pro AD Restoraderm, que teve sua fórmula aprimorada com a tecnologia AD-Resyl14-15, fundamental na manutenção do microbioma da pele16, alivia a coceira17 e fornece hidratação duradoura18. Também pode ser utilizado em crianças a partir dos 3 meses de idade19 – 100% das mães relataram que o produto ajudou a reduzir a sensibilidade da pele do seu filho com o uso contínuo durante 21 dias*.

A linha ainda conta com o sabonete líquido e espuma hidratante:

O uso do Sabonete Líquido Cetaphil Pro AD Restoraderm é mais adequado para a pele com eczema do que utilizar apenas água21. O produto, de uso diário, ajuda a aliviar o desconforto da pele atópica22-23 e é de fácil enxágue, deixando a pele macia e suave, proporcionando uma sensação de limpeza saudável23-24.

A Espuma Hidratante Cetaphil Pro AD Fast Control age de maneira rápida no controle do prurido25*. Foi formulado especialmente para uso na pele sensível em momentos de exacerbação de ressecamento e irritação26*. Além disso, 98% dos usuários sentiram que o produto é absorvido rapidamente pela pele27**.

Antes de utilizar qualquer produto, consulte um dermatologista.

1 RD.06.SPR.18152
2Pesquisa realizada com 200 dermatologistas © Inception | Dezembro de 2022.
**93% dos profissionais entrevistados recomendam Cetaphil para hidratação corporal © Inception | Dezembro de 2022; Ref: 9 em cada 10 Dermatologistas recomendam Cetaphil
3 Estudo de percepção realizado com 43 participantes
4Repair and Maintenance of the Epidermal Barrier in Patients Diagnosed with Atopic Dermatitis
5 RD.06.SPR.18152
6 Sponsor Reference B211082SSP 204912 P3021 (FIL 1808)
7-8Safety and Tolerability of a Body Wash and Moisturizer When Applied to Infants and Toddlers with a H  9-10 RD.03.SPR.105314 / P614
11-12RD.27.SPR.204713 P3021 (FIL 1808)
13RD.53.SPR.204717 P3021 (FIL 1808)
14 Role of Antimicrobial Peptides in Skin Barrier Repairin Individuals with Atopic Dermatitis
15 Cinical Efficacy of Oligofructans from Ophiopogon japonicus inReducing Atopic Dermatitis Flare-ups in Caucasian Patiente
16 RD.06.SPR.18152
17-18 Sponsor Project No. 429 I 40066
19Safety and Tolerability of a Body Wash and Moisturizer When Applied to Infants and Toddlers with a H / *estudo realizado com 44 participantes
21Skin pH: From Basic Science to Basic Skin Care
22 RD.06.SPR.18151
23 GLI.04.SRE.US10154 
24 Tolerability and cosmetic acceptability of a body wash in atopic dermatitis-prone subjects
25 Efficacy of a MoistUI-izing Foam im Skin Barrier. Regeneration and Itch Relief in Subjects Prone to 
26 RD.03.SPR. 108812
*Relacionado ao ressecamento da pele
27 RD.03.SPR.104187/P614
**Estudo realizado com 41 participantes durante 28 dias

Sobre a Galderma 
A Galderma é a empresa líder na categoria dedicada ao avanço de soluções para o cuidado da pele, presente em aproximadamente 90 países. Fornecemos um portfólio inovador e baseado em ciência de marcas e serviços premium que abrangem todo o espectro de dermatologia em rápido crescimento por meio de Estética Injetável, Skincare Dermatológico e Dermatologia Terapêutica. Desde nossa fundação em 1981, dedicamos nosso foco e paixão ao maior órgão do corpo humano – a pele – atendendo às necessidades individuais de consumidores e pacientes com resultados superiores em parceria com profissionais de saúde. Estamos avançando a dermatologia para cada história de pele, porque entendemos que a pele em que estamos molda nossas histórias de vida. O portfólio de marcas emblemáticas da Galderma inclui Restylane e Sculptra em Estética Injetável; Cetaphil, Dermotivin e Benzac em Skincare Dermatológico; além dos medicamentos prescritos para Acne e Rosácea em Dermatologia Terapêutica. Para mais informações: www.galderma.com/br e galdermaaesthetics.com.br

Foto - https://mma.prnewswire.com/media/2201969/1000x1000_Creme_Reparador_Frente_copy.jpg

Foto - https://mma.prnewswire.com/media/2201970/Lo__o_145mL_PRO_AD.jpg

Foto - https://mma.prnewswire.com/media/2201971/PRO_AD_LOCAO_HIDRA_295ml_frente_1000x1000.jpg

Foto - https://mma.prnewswire.com/media/2201973/PRO_AD_SABONETE_LIQUIDO_frente_1000x1000px.jpg

Foto - https://mma.prnewswire.com/media/2201972/Frasco_EspumaHidratPROAD100ml_pose01_1000px_op2.jpg

FONTE Galderma

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the establishment of its new U.S. headquarters in Miami, Florida,...

GALDERMA LAUNCHES "SCRATCH RESISTANCE" CAMPAIGN TO VALIDATE THE PHYSICAL AND EMOTIONAL BURDENS OF ATOPIC DERMATITIS

GALDERMA LAUNCHES "SCRATCH RESISTANCE" CAMPAIGN TO VALIDATE THE PHYSICAL AND EMOTIONAL BURDENS OF ATOPIC DERMATITIS

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the launch of "Scratch Resistance," its new broadcast advertisement...

More Releases From This Source

Explore

Cosmetics and Personal Care

Cosmetics and Personal Care

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

Retail

Retail

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.